1038 related articles for article (PubMed ID: 28663251)
1. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
4. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
6. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
[TBL] [Abstract][Full Text] [Related]
8. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
[TBL] [Abstract][Full Text] [Related]
11. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
Abbasalizad Farhangi M; Vajdi M
Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
[TBL] [Abstract][Full Text] [Related]
13. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
14. Novel findings of the association between gut microbiota-derived metabolite trimethylamine
Farhangi MA; Vajdi M
Crit Rev Food Sci Nutr; 2020; 60(16):2801-2823. PubMed ID: 32462890
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
17. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
[TBL] [Abstract][Full Text] [Related]
18. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
[TBL] [Abstract][Full Text] [Related]
20. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
Yu D; Shu XO; Rivera ES; Zhang X; Cai Q; Calcutt MW; Xiang YB; Li H; Gao YT; Wang TJ; Zheng W
J Am Heart Assoc; 2019 Jan; 8(1):e010606. PubMed ID: 30606084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
